Astrana Health, Inc. (NASDAQ:ASTH) Sees Large Decline in Short Interest

Astrana Health, Inc. (NASDAQ:ASTH - Get Free Report) saw a large drop in short interest in January. As of January 15th, there was short interest totalling 1,490,000 shares, a drop of 8.6% from the December 31st total of 1,630,000 shares. Currently, 4.2% of the shares of the company are sold short. Based on an average daily volume of 303,600 shares, the days-to-cover ratio is presently 4.9 days.

Astrana Health Price Performance

Shares of NASDAQ:ASTH traded down $0.46 during trading on Wednesday, reaching $36.53. The stock had a trading volume of 211,666 shares, compared to its average volume of 367,891. The stock has a market capitalization of $2.05 billion, a PE ratio of 28.10, a P/E/G ratio of 1.42 and a beta of 1.20. Astrana Health has a 52 week low of $29.08 and a 52 week high of $63.20. The business's 50-day moving average price is $36.04 and its 200 day moving average price is $46.13. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.91 and a quick ratio of 1.91.

Astrana Health (NASDAQ:ASTH - Get Free Report) last issued its quarterly earnings data on Thursday, November 7th. The company reported $0.33 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.33. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. The firm had revenue of $478.71 million during the quarter, compared to the consensus estimate of $462.01 million. During the same quarter in the previous year, the company posted $0.47 EPS. As a group, equities analysts predict that Astrana Health will post 1.15 earnings per share for the current year.

Hedge Funds Weigh In On Astrana Health

A number of institutional investors have recently modified their holdings of ASTH. GAMMA Investing LLC acquired a new stake in shares of Astrana Health in the third quarter valued at approximately $34,000. Nisa Investment Advisors LLC acquired a new stake in shares of Astrana Health in the 3rd quarter valued at $35,000. KBC Group NV bought a new stake in shares of Astrana Health during the third quarter worth $70,000. Quarry LP acquired a new position in shares of Astrana Health during the third quarter valued at $77,000. Finally, Quest Partners LLC bought a new position in Astrana Health in the third quarter valued at about $133,000. 52.77% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several research analysts recently commented on the company. KeyCorp started coverage on Astrana Health in a research report on Friday, October 11th. They issued a "sector weight" rating for the company. Macquarie upgraded shares of Astrana Health to a "hold" rating in a research note on Monday, December 16th. Truist Financial decreased their target price on shares of Astrana Health from $59.00 to $50.00 and set a "buy" rating on the stock in a research report on Monday, January 13th. Robert W. Baird raised their price target on shares of Astrana Health from $67.00 to $86.00 and gave the stock an "outperform" rating in a research note on Wednesday, November 13th. Finally, TD Cowen began coverage on Astrana Health in a report on Monday, October 14th. They issued a "buy" rating and a $66.00 target price for the company. Two equities research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $63.67.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.